chr3-49419325-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000481.4(AMT):​c.631G>A​(p.Glu211Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00878 in 1,614,230 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E211E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0079 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0089 ( 109 hom. )

Consequence

AMT
NM_000481.4 missense

Scores

6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.57

Publications

17 publications found
Variant links:
Genes affected
AMT (HGNC:473): (aminomethyltransferase) This gene encodes one of four critical components of the glycine cleavage system. Mutations in this gene have been associated with glycine encephalopathy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
AMT Gene-Disease associations (from GenCC):
  • glycine encephalopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • glycine encephalopathy 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • infantile glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atypical glycine encephalopathy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008803636).
BP6
Variant 3-49419325-C-T is Benign according to our data. Variant chr3-49419325-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 462898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00791 (1205/152350) while in subpopulation SAS AF = 0.0174 (84/4832). AF 95% confidence interval is 0.0144. There are 5 homozygotes in GnomAd4. There are 601 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMTNM_000481.4 linkc.631G>A p.Glu211Lys missense_variant Exon 6 of 9 ENST00000273588.9 NP_000472.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMTENST00000273588.9 linkc.631G>A p.Glu211Lys missense_variant Exon 6 of 9 1 NM_000481.4 ENSP00000273588.3
ENSG00000283189ENST00000636166.1 linkc.868G>A p.Glu290Lys missense_variant Exon 8 of 11 5 ENSP00000490106.1

Frequencies

GnomAD3 genomes
AF:
0.00790
AC:
1202
AN:
152232
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00183
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.00746
Gnomad ASJ
AF:
0.0170
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0167
Gnomad FIN
AF:
0.0131
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00994
Gnomad OTH
AF:
0.0138
GnomAD2 exomes
AF:
0.0105
AC:
2635
AN:
250992
AF XY:
0.0117
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00581
Gnomad ASJ exome
AF:
0.0203
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0121
Gnomad NFE exome
AF:
0.0113
Gnomad OTH exome
AF:
0.0132
GnomAD4 exome
AF:
0.00888
AC:
12975
AN:
1461880
Hom.:
109
Cov.:
31
AF XY:
0.00949
AC XY:
6901
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00119
AC:
40
AN:
33480
American (AMR)
AF:
0.00660
AC:
295
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0194
AC:
506
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.0182
AC:
1569
AN:
86256
European-Finnish (FIN)
AF:
0.0116
AC:
620
AN:
53408
Middle Eastern (MID)
AF:
0.0270
AC:
156
AN:
5768
European-Non Finnish (NFE)
AF:
0.00825
AC:
9172
AN:
1112012
Other (OTH)
AF:
0.0102
AC:
614
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1000
1999
2999
3998
4998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00791
AC:
1205
AN:
152350
Hom.:
5
Cov.:
32
AF XY:
0.00807
AC XY:
601
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00183
AC:
76
AN:
41580
American (AMR)
AF:
0.00745
AC:
114
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0170
AC:
59
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0174
AC:
84
AN:
4832
European-Finnish (FIN)
AF:
0.0131
AC:
139
AN:
10628
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00994
AC:
676
AN:
68026
Other (OTH)
AF:
0.0137
AC:
29
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00940
Hom.:
18
Bravo
AF:
0.00720
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00907
AC:
78
ExAC
AF:
0.0109
AC:
1327
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0126
EpiControl
AF:
0.0131

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycine encephalopathy Benign:7
Jul 10, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AMT: BS1, BS2 -

Sep 11, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.60
D;.;.;T;T;T;.;.;T;T;.;.
Eigen
Benign
0.092
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.64
D
LIST_S2
Uncertain
0.95
D;D;D;D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0088
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.19
N;N;.;.;.;.;.;.;.;.;.;.
PhyloP100
2.6
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.5
N;N;N;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.44
Sift
Benign
0.66
T;T;T;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.80
T;T;T;.;.;.;.;.;.;.;.;.
Polyphen
0.019
B;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.18
MPC
0.23
ClinPred
0.0099
T
GERP RS
3.6
PromoterAI
0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.37
gMVP
0.62
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116192290; hg19: chr3-49456758; COSMIC: COSV99060223; COSMIC: COSV99060223; API